Preserving the reproductive potential of men and boys with cancer: current concepts and future prospects.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 15319377)

Published in Hum Reprod Update on August 19, 2004

Authors

Herman Tournaye1, Ellen Goossens, Greta Verheyen, Veerle Frederickx, Gert De Block, Paul Devroey, André Van Steirteghem

Author Affiliations

1: Centre for Reproductive Medicine, Dutch-speaking Free University Brussels, Brussels, Belgium. tournaye@az.vub.ac.be

Articles citing this

Fertility preservation and adolescent cancer patients: lessons from adult survivors of childhood cancer and their parents. Cancer Treat Res (2007) 1.59

Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia. J Clin Invest (2005) 1.11

Male factor infertility and ART. Asian J Androl (2011) 0.97

Sperm banking for male reproductive preservation: a 6-year retrospective multi-centre study in China. Asian J Androl (2010) 0.93

Sperm cryopreservation practices among adolescent cancer patients at risk for infertility. Pediatr Hematol Oncol (2009) 0.92

Fertility preservation in young cancer patients. J Hum Reprod Sci (2010) 0.87

Can Urol Assoc J (2009) 0.85

"Just what the doctor ordered": Factors associated with oncology patients' decision to bank sperm. Can Urol Assoc J (2011) 0.84

Effects of vitamin A on in vitro maturation of pre-pubertal mouse spermatogonial stem cells. PLoS One (2013) 0.80

Achieving high survival rate following cryopreservation after isolation of prepubertal mouse spermatogonial cells. J Assist Reprod Genet (2009) 0.80

The effects of poly L-lactic acid nanofiber scaffold on mouse spermatogonial stem cell culture. Int J Nanomedicine (2013) 0.79

Adverse effects of common medications on male fertility. Nat Rev Urol (2015) 0.79

Male fertility preservation before gonadotoxic therapies. Facts Views Vis Obgyn (2010) 0.78

Fertility preservation for boys and adolescents facing sterilizing medical therapy. Transl Androl Urol (2014) 0.78

Preconception and the young cancer survivor. Matern Child Health J (2006) 0.76

Fertility Preservation Options for Men and Women With Cancer. Rev Urol (2015) 0.76

Evaluation of ebselen supplementation on cryopreservation medium in human semen. Iran J Reprod Med (2014) 0.76

Spermatogonial stem cells: What does the future hold? Facts Views Vis Obgyn (2011) 0.75

The effect of the melatonin on cryopreserved mouse testicular cells. Int J Reprod Biomed (Yazd) (2016) 0.75

Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure? Nat Rev Urol (2016) 0.75

Articles by these authors

Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod (2004) 3.56

Infertility and the provision of infertility medical services in developing countries. Hum Reprod Update (2008) 3.31

Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. Reprod Biomed Online (2011) 2.79

Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet (2005) 2.73

In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med (2006) 2.41

Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod (2006) 2.18

Intracytoplasmic sperm injection versus in vitro fertilization: a randomized controlled trial and a meta-analysis of the literature. Fertil Steril (2002) 2.16

Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained recurrent miscarriages. Fertil Steril (2005) 2.09

Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999). Hum Reprod (2002) 1.98

Whole-genome multiple displacement amplification from single cells. Nat Protoc (2006) 1.88

A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril (2011) 1.85

Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod (2007) 1.82

Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril (2006) 1.81

Primary ovarian insufficiency. Lancet (2010) 1.67

Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. Hum Reprod Update (2008) 1.67

Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod (2007) 1.66

Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reprod Biomed Online (2006) 1.56

Preimplantation genetic diagnosis. Lancet (2004) 1.52

Orthotopic grafting of cryopreserved prepubertal testicular tissue: in search of a simple yet effective cryopreservation protocol. Fertil Steril (2012) 1.52

Clinical validation of a closed vitrification system in an oocyte-donation programme. Reprod Biomed Online (2011) 1.51

Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation. Hum Reprod (2004) 1.47

Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod (2002) 1.46

Are ICSI adolescents at risk for increased adiposity? Hum Reprod (2011) 1.45

The endometrium in stimulated cycles for IVF. Hum Reprod Update (2004) 1.44

POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells (2006) 1.43

Testicular cell transplantation into the human testes. Fertil Steril (2013) 1.42

"Floating denominators"--effect of verification bias on accuracy estimates for preimplantation diagnosis. Fertil Steril (2003) 1.39

Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study. Hum Reprod (2005) 1.38

Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril (2003) 1.32

Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril (2002) 1.31

Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure. Fertil Steril (2005) 1.24

Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod (2005) 1.23

Influence of individual sperm morphology on fertilization, embryo morphology, and pregnancy outcome of intracytoplasmic sperm injection. Fertil Steril (2003) 1.20

Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab (2003) 1.19

Generation of lung epithelial-like tissue from human embryonic stem cells. Respir Res (2009) 1.18

Methylation analysis of the intergenic differentially methylated region of DLK1-GTL2 in human. Eur J Hum Genet (2007) 1.16

Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle. Fertil Steril (2010) 1.15

No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part I, corifollitropin alfa. Reprod Biomed Online (2011) 1.15

Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril (2004) 1.14

Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes. Hum Reprod (2005) 1.12

Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review. Hum Reprod (2004) 1.12

Assisted reproduction and thyroid autoimmunity: an unfortunate combination? J Clin Endocrinol Metab (2003) 1.11

Spermatogonial survival after grafting human testicular tissue to immunodeficient mice. Hum Reprod (2005) 1.10

Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years. Fertil Steril (2005) 1.10

Human oocytes reversibly arrested in prophase I by phosphodiesterase type 3 inhibitor in vitro. Biol Reprod (2003) 1.05

Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos. Hum Reprod (2009) 1.05

Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod (2004) 1.05

Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril (2007) 1.04

Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles. Reprod Biomed Online (2006) 1.04

Chromosomal segregation in spermatozoa of 14 Robertsonian translocation carriers. Mol Hum Reprod (2006) 1.03

In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expression. Hum Reprod (2009) 1.03

Ex-vivo oocyte retrieval for fertility preservation. Fertil Steril (2010) 1.02

Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Hum Reprod (2006) 1.01

Methylation imprints of the imprint control region of the SNRPN-gene in human gametes and preimplantation embryos. Hum Mol Genet (2003) 1.01

Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology--assisted reproduction technology. Gynecol Endocrinol (2015) 1.01

Infertility therapy-associated multiple pregnancies (births): an ongoing epidemic. Reprod Biomed Online (2003) 1.01

A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study. Fertil Steril (2010) 0.99

Autologous spermatogonial stem cell transplantation in man: current obstacles for a future clinical application. Hum Reprod Update (2008) 0.99

The four blastomeres of a 4-cell stage human embryo are able to develop individually into blastocysts with inner cell mass and trophectoderm. Hum Reprod (2008) 0.98

Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system. Reprod Biomed Online (2004) 0.98

Thyroid dysfunction and autoimmunity in infertile women. Thyroid (2002) 0.98

Getting pregnant after tubal sterilization: surgical reversal or IVF? Hum Reprod (2007) 0.98

Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study. Fertil Steril (2012) 0.97

Developmental capacity of in vitro-matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm. Fertil Steril (2012) 0.97

Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome. Fertil Steril (2011) 0.97

Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. Fertil Steril (2003) 0.96

Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod (2005) 0.96

Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial. Hum Reprod (2007) 0.96

Abnormal sperm in mice with targeted deletion of the act (activator of cAMP-responsive element modulator in testis) gene. Proc Natl Acad Sci U S A (2004) 0.95

Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Reprod Biomed Online (2011) 0.95

Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. Fertil Steril (2007) 0.95

Plagiarism, retraction and the future. Hum Reprod (2011) 0.94

Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles. Fertil Steril (2004) 0.94

Spermatogonial survival in long-term human prepubertal xenografts. Fertil Steril (2008) 0.94

Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertil Steril (2007) 0.94

Effect of ovarian stimulation and oocyte retrieval on reproductive outcome in oocyte donors. Fertil Steril (2012) 0.93

Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunity. J Clin Endocrinol Metab (2004) 0.93

Efficient differentiation of human embryonic stem cells into a homogeneous population of osteoprogenitor-like cells. Reprod Biomed Online (2008) 0.93

Osmotic responses and tolerance limits to changes in external osmolalities, and oolemma permeability characteristics, of human in vitro matured MII oocytes. Hum Reprod (2007) 0.93